{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:32:32Z","timestamp":1782253952275,"version":"3.54.5"},"reference-count":68,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.7873","type":"journal-article","created":{"date-parts":[[2018,1,26]],"date-time":"2018-01-26T09:18:44Z","timestamp":1516958324000},"source":"Crossref","is-referenced-by-count":13,"title":["Diagnostic significance of CK19, galectin-3, CD56, TPO and Ki67 expression and BRAF mutation in papillary thyroid carcinoma"],"prefix":"10.3892","author":[{"given":"Lihua","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Pathology, Wuhan Puai Hospital, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuming","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Jiangda Pathology Institute, Jianghan University, Wuhan, Hubei 430056, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Jiangda Pathology Institute, Jianghan University, Wuhan, Hubei 430056, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Gui","sequence":"additional","affiliation":[{"name":"Department of Pathology, Wuhan Puai Hospital, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Jiangda Pathology Institute, Jianghan University, Wuhan, Hubei 430056, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongxia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Jiangda Pathology Institute, Jianghan University, Wuhan, Hubei 430056, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongling","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Wuhan Puai Hospital, Wuhan, Hubei 430030, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Jiangda Pathology Institute, Jianghan University, Wuhan, Hubei 430056, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2018,1,26]]},"reference":[{"key":"key20200714002750_b1-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrendo.2012.257","article-title":"Increasing incidence of thyroid cancer: Controversies explored","volume":"9","author":"Ito","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"key20200714002750_b2-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4143\/crt.2013.45.1.1","article-title":"Cancer statistics in Korea: Incidence, mortality, survival and prevalence in 2010","volume":"45","author":"Jung","year":"2013","journal-title":"Cancer Res Treat"},{"key":"key20200714002750_b3-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1507\/endocrj.EJ12-0362","article-title":"Incidence and predictors of right paraesophageal lymph node metastasis of N0 papillary thyroid carcinoma located in the right lobe","volume":"60","author":"Ito","year":"2013","journal-title":"Endocr J"},{"key":"key20200714002750_b4-ol-0-0-7873","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4103\/0973-1482.138134","article-title":"Incidence of occult papillary carcinoma of thyroid in Indian population: Case series and review of literature","volume":"10","author":"Joshi","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"key20200714002750_b5-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.surg.2015.12.026","article-title":"Incidence of metastases from 524 patients with papillary thyroid carcinoma in cervical lymph nodes posterior to the sternoclavicular joint (level VIa): Relevance for endoscopic thyroidectomy","volume":"159","author":"Wang","year":"2016","journal-title":"Surgery"},{"key":"key20200714002750_b6-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s13000-015-0346-5","article-title":"Clinicopathological features of recurrent papillary thyroid cancer","volume":"10","author":"Zhu","year":"2015","journal-title":"Diagn Pathol"},{"key":"key20200714002750_b7-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1148\/radiol.14140481","article-title":"Papillary thyroid cancer: Dual-energy spectral CT quantitative parameters for preoperative diagnosis of metastasis to the cervical lymph nodes","volume":"275","author":"Liu","year":"2015","journal-title":"Radiology"},{"key":"key20200714002750_b8-ol-0-0-7873","first-page":"2901","article-title":"Prognostic significance of DLL4 expression in papillary thyroid cancer","volume":"19","author":"Zhang","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20200714002750_b9-ol-0-0-7873","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3760\/cma.j.issn.0366-6999.20130172","article-title":"Correlations between papillary thyroid cancer and peripheral blood levels of matrix metalloproteinase-2, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and tissue inhibitor of metalloproteinase-2","volume":"126","author":"Zhou","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"key20200714002750_b10-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12957-016-0776-x","article-title":"Papillary thyroid cancer located in malignant struma ovarii with omentum metastasis: A case report and review of the literature","volume":"14","author":"Zhu","year":"2016","journal-title":"World J Surg Oncol"},{"key":"key20200714002750_b11-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.3892\/ijo.2016.3412","article-title":"Expression, clinical significance and mechanism of Slit2 in papillary thyroid cancer","volume":"48","author":"Shi","year":"2016","journal-title":"Int J Oncol"},{"key":"key20200714002750_b12-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"8383","DOI":"10.1007\/s13277-015-4718-y","article-title":"Relationship of body mass index with BRAF (V600E) mutation in papillary thyroid cancer","volume":"37","author":"Shi","year":"2016","journal-title":"Tumour Biol"},{"key":"key20200714002750_b13-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1210\/jc.2015-2917","article-title":"Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants","volume":"101","author":"Shi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"key20200714002750_b14-ol-0-0-7873","doi-asserted-by":"crossref","first-page":"16716","DOI":"10.18632\/oncotarget.7574","article-title":"Radiation exposure, young age, and female gender are associated with high prevalence of RET\/PTC1 and RET\/PTC3 in papillary thyroid cancer: A meta-analysis","volume":"7","author":"Su","year":"2016","journal-title":"Oncotarget"},{"key":"key20200714002750_b15-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"778","DOI":"10.7150\/ijms.5129","article-title":"Peri-operative treatment of giant nodular goiter","volume":"9","author":"Gao","year":"2012","journal-title":"Int J Med Sci"},{"key":"key20200714002750_b16-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1111\/ajco.12480","article-title":"The significance of Delphian lymph node in papillary thyroid cancer","volume":"13","author":"Tan","year":"2017","journal-title":"Asia Pac J Clin Oncol"},{"key":"key20200714002750_b17-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s11596-015-1476-4","article-title":"BRAF(V600E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis","volume":"35","author":"Ma","year":"2015","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"key20200714002750_b18-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3892\/mco.2015.495","article-title":"Outcome of papillary thyroid microcarcinoma: Study of 1,990 cases","volume":"3","author":"Lu","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"key20200714002750_b19-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s00268-015-3108-3","article-title":"Risk factors for central compartment lymph node metastasis in papillary thyroid microcarcinoma: A meta-analysis","volume":"39","author":"Qu","year":"2015","journal-title":"World J Surg"},{"key":"key20200714002750_b20-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.7314\/APJCP.2015.16.8.3361","article-title":"Risk factors for nodal metastasis in cN0 papillary thyroid microcarcinoma","volume":"16","author":"Zhang","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20200714002750_b21-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12957-015-0553-2","article-title":"The clinical prognosis of patients with cN0 papillary thyroid microcarcinoma by central neck dissection","volume":"13","author":"Zhang","year":"2015","journal-title":"World J Surg Oncol"},{"key":"key20200714002750_b22-ol-0-0-7873","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hed.21142","article-title":"Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings","volume":"32","author":"Park","year":"2010","journal-title":"Head Neck"},{"key":"key20200714002750_b23-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1089\/thy.2008.0185","article-title":"Papillary thyroid carcinoma and microcarcinoma: Is there a need to distinguish the two?","volume":"19","author":"Arora","year":"2009","journal-title":"Thyroid"},{"key":"key20200714002750_b24-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s12022-008-9035-1","article-title":"Differential expression of dysadherin in papillary thyroid carcinoma and microcarcinoma: Correlation with E-cadherin","volume":"19","author":"Batistatou","year":"2008","journal-title":"Endocr Pathol"},{"key":"key20200714002750_b25-ol-0-0-7873","first-page":"63","article-title":"Survivin and cyclin D1 are jointly expressed in thyroid papillary carcinoma and microcarcinoma","volume":"20","author":"Antonaci","year":"2008","journal-title":"Oncol Rep"},{"key":"key20200714002750_b26-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1752-1947-2-42","article-title":"Papillary carcinoma arising in a thyroglossal duct cyst with associated microcarcinoma of the thyroid and without cervical lymph node metastasis: A case report","volume":"2","author":"Kandogan","year":"2008","journal-title":"J Med Case Rep"},{"key":"key20200714002750_b27-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1365-2265.2005.02386.x","article-title":"Thyroid papillary cancers: Microcarcinoma and carcinoma, incidental cancers and non-incidental cancers-are they different diseases?","volume":"63","author":"Barbaro","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20200714002750_b28-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3322\/caac.21195","article-title":"New developments in the diagnosis and treatment of thyroid cancer","volume":"63","author":"Schneider","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"key20200714002750_b29-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200714002750_b30-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"429","DOI":"10.7705\/biomedica.v35i3.2598","article-title":"Histological variants and prognostic factors of papillary thyroid carcinoma at the Colombian Instituto Nacional de Cancerologia, 2006\u20132012","volume":"35","author":"Romero-Rojas","year":"2015","journal-title":"Biomedica"},{"key":"key20200714002750_b31-ol-0-0-7873","first-page":"S34","article-title":"Variants of papillary thyroid carcinoma: Multiple faces of a familiar tumor","volume":"31","author":"Sak","year":"2015","journal-title":"Turk Patoloji Derg"},{"key":"key20200714002750_b32-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7863\/ultra.34.1.1","article-title":"Sonographic and cytopathologic correlation of papillary thyroid carcinoma variants","volume":"34","author":"Lee","year":"2015","journal-title":"J Ultrasound Med"},{"key":"key20200714002750_b33-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1746-1596-6-126","article-title":"Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China","volume":"6","author":"Song","year":"2011","journal-title":"Diagn Pathol"},{"key":"key20200714002750_b34-ol-0-0-7873","first-page":"25","article-title":"Expressions of D2-40, CK19, galectin-3, VEGF and EGFR in papillary thyroid carcinoma","volume":"1","author":"Gong","year":"2012","journal-title":"Gland Surg"},{"key":"key20200714002750_b35-ol-0-0-7873","first-page":"4369","article-title":"Significance of CK19, TPO, and HBME-1 expression for diagnosis of papillary thyroid carcinoma","volume":"8","author":"Liu","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"key20200714002750_b36-ol-0-0-7873","first-page":"103","article-title":"Expression of galectin-3, cytokeratin 19, neural cell adhesion molecule and E-cadhedrin in certain variants of papillary thyroid carcinoma","volume":"44","author":"Laco","year":"2008","journal-title":"Cesk Patol"},{"key":"key20200714002750_b37-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1309\/AJCPCGCZZ1OYF0IC","article-title":"Absence of the BRAF mutation in HBME1+ and CK19+ atypical cell clusters in Hashimoto thyroiditis: Supportive evidence against preneoplastic change","volume":"132","author":"Nasr","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"key20200714002750_b38-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13000-015-0262-8","article-title":"Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential","volume":"10","author":"Lamba Saini","year":"2015","journal-title":"Diagn Pathol"},{"key":"key20200714002750_b39-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"e0134458","DOI":"10.1371\/journal.pone.0134458","article-title":"Hypoxia up-regulates galectin-3 in mammary tumor progression and metastasis","volume":"10","author":"de Oliveira","year":"2015","journal-title":"PloS One"},{"key":"key20200714002750_b40-ol-0-0-7873","first-page":"7999","article-title":"Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma-like nuclear alterations in Hashimoto's thyroiditis","volume":"7","author":"Ma","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"key20200714002750_b41-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2147\/OTT.S94514","article-title":"Galectin-3 may serve as a potential marker for diagnosis and prognosis in papillary thyroid carcinoma: A meta-analysis","volume":"9","author":"Tang","year":"2016","journal-title":"OncoTargets Ther"},{"key":"key20200714002750_b42-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/dc.23408","article-title":"Can galectin-3 be a useful marker for conventional papillary thyroid microcarcinoma?","volume":"44","author":"Gweon","year":"2016","journal-title":"Diagn Cytopathol"},{"key":"key20200714002750_b43-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/02841860701630242","article-title":"Papillary microcarcinoma of the thyroid gland: Is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?","volume":"47","author":"Londero","year":"2008","journal-title":"Acta Oncol"},{"key":"key20200714002750_b44-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13000-015-0428-4","article-title":"Defining the value of CD56, CK19, galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature","volume":"10","author":"Dun\u0111erovi\u0107","year":"2015","journal-title":"Diagn Pathol"},{"key":"key20200714002750_b45-ol-0-0-7873","first-page":"599","article-title":"Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions","volume":"33","author":"Tong","year":"2011","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"key20200714002750_b46-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13044-015-0022-6","article-title":"The value of thyroperoxidase as a prognostic factor for differentiated thyroid cancer-a long-term follow-up study","volume":"8","author":"Caballero","year":"2015","journal-title":"Thyroid Res"},{"key":"key20200714002750_b47-ol-0-0-7873","first-page":"2304","article-title":"Cytokeratin 19, thyroperoxidase, HBME-1 and galectin-3 in evaluation of aggressive behavior of papillary thyroid carcinoma","volume":"7","author":"Liu","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"key20200714002750_b48-ol-0-0-7873","first-page":"678","article-title":"Detection of cytokeratin 19 and thyroperoxidase expressions in the diagnosis of thyroid diseases","volume":"25","author":"Yang","year":"2005","journal-title":"Di Yi Jun Yi Da Xue Xue Bao"},{"key":"key20200714002750_b49-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"e0132939","DOI":"10.1371\/journal.pone.0132939","article-title":"The role of CD56 in thyroid fine needle aspiration cytology: A pilot study performed on liquid based cytology","volume":"10","author":"Bizzarro","year":"2015","journal-title":"PloS One"},{"key":"key20200714002750_b50-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/path.2183","article-title":"Papillary carcinoma of the thyroid: Low expression of NCAM (CD56) is associated with downregulation of VEGF-D production by tumour cells","volume":"212","author":"Scarpino","year":"2007","journal-title":"J Pathol"},{"key":"key20200714002750_b51-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.7314\/APJCP.2015.16.4.1605","article-title":"Expression of ki67 in papillary thyroid microcarcinoma and its clinical significance","volume":"16","author":"Zhou","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20200714002750_b52-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1089\/thy.2013.0573","article-title":"Hobnail variant of papillary thyroid carcinoma: An institutional case series and molecular profile","volume":"24","author":"Lubitz","year":"2014","journal-title":"Thyroid"},{"key":"key20200714002750_b53-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1369\/0022155412447296","article-title":"Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors","volume":"60","author":"Clinckspoor","year":"2012","journal-title":"J Histochem Cytochem"},{"key":"key20200714002750_b54-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/1471-2407-14-383","article-title":"Differential expression patterns and clinical significance of estrogen receptor-\u03b1 and \u03b2 in papillary thyroid carcinoma","volume":"14","author":"Huang","year":"2014","journal-title":"BMC Cancer"},{"key":"key20200714002750_b55-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1089\/thy.2014.0338","article-title":"Relevance of BRAF(V600E) mutation testing versus RAS point mutations and RET\/PTC rearrangements evaluation in the diagnosis of thyroid cancer","volume":"25","author":"Rossi","year":"2015","journal-title":"Thyroid"},{"key":"key20200714002750_b56-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"603","DOI":"10.7314\/APJCP.2016.17.2.603","article-title":"Mutation analysis of KRAS and BRAF genes in metastatic colorectal cancer: A first large scale study from Iran","volume":"17","author":"Koochak","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20200714002750_b57-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"134","DOI":"10.5858\/arpa.2014-0612-OA","article-title":"Mutation in BRAF and other members of the MAPK pathway in papillary thyroid carcinoma in the pediatric population","volume":"140","author":"Gertz","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"key20200714002750_b58-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1089\/thy.2015.0352","article-title":"Increase in papillary thyroid cancer incidence is accompanied by changes in the frequency of the BRAF V600E mutation: A single-institution study","volume":"26","author":"Kowalska","year":"2016","journal-title":"Thyroid"},{"key":"key20200714002750_b59-ol-0-0-7873","first-page":"22525","article-title":"Correlation between the BRAF(v600E) gene mutation and factors influencing the prognosis of papillary thyroid microcarcinoma","volume":"8","author":"Sun","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"key20200714002750_b60-ol-0-0-7873","first-page":"22246","article-title":"The BRAF V600E mutation predicts poor survival outcome in patients with papillary thyroid carcinoma: A meta analysis","volume":"8","author":"Li","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"key20200714002750_b61-ol-0-0-7873","first-page":"21327","article-title":"Clinical significance of preoperative detection of serum p53 antibodies and BRAF(V600E) mutation in patients with papillary thyroid carcinoma","volume":"8","author":"Fu","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"key20200714002750_b62-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5603\/EP.2016.0006","article-title":"The usefulness of determining the presence of BRAF V600E mutation in fine-needle aspiration cytology in indeterminate cytological results","volume":"67","author":"Kowalska","year":"2016","journal-title":"Endokrynol Pol"},{"key":"key20200714002750_b63-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"35","DOI":"10.5603\/EP.2016.0005","article-title":"The value of the repeated examination of BRAF V600E mutation status in diagnostics of papillary thyroid cancer","volume":"67","author":"Bei\u0161a","year":"2016","journal-title":"Endokrynol Pol"},{"key":"key20200714002750_b64-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"bcr2015212772","DOI":"10.1136\/bcr-2015-212772","article-title":"Perianal melanoma with a BRAF gene mutation in a young Portuguese Roma native","volume":"2016","author":"Tan","year":"2016","journal-title":"BMJ Case Rep"},{"key":"key20200714002750_b65-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1089\/thy.2013.0610","article-title":"Concomitant RAS RET\/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma","volume":"24","author":"Zou","year":"2014","journal-title":"Thyroid"},{"key":"key20200714002750_b66-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1158\/1078-0432.CCR-08-0933","article-title":"High rate of BRAF and RET\/PTC dual mutations associated with recurrent papillary thyroid carcinoma","volume":"15","author":"Henderson","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20200714002750_b67-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1530\/ERC-14-0531","article-title":"BRAFV600E mutation in papillary thyroid microcarcinoma: A meta-analysis","volume":"22","author":"Li","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"key20200714002750_b68-ol-0-0-7873","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1756-6614-7-6","article-title":"New insights into the diagnosis of nodular goiter","volume":"7","author":"Syrenicz","year":"2014","journal-title":"Thyroid Res"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T19:14:31Z","timestamp":1719774871000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.7873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,26]]},"references-count":68,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.7873","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,26]]}}}